Year |
Citation |
Score |
2024 |
Huang KB, Wang FY, Lu Y, Yang LM, Long N, Wang SS, Xie Z, Levine M, Zou T, Sessler JL, Liang H. Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 121: e2404668121. PMID 38833473 DOI: 10.1073/pnas.2404668121 |
0.316 |
|
2023 |
Jiang J, Xiong X, Zou T. Modulating the Chemical Reactivity of Gold Complexes in Living Systems: From Concept to Biomedical Applications. Accounts of Chemical Research. 56: 1043-1056. PMID 37079555 DOI: 10.1021/acs.accounts.3c00037 |
0.409 |
|
2022 |
Jiang J, Cao B, Chen Y, Luo H, Xue J, Xiong X, Zou T. Alkylgold(III) Complexes Undergo Unprecedented Photo-Induced β-Hydride Elimination and Reduction for Targeted Cancer Therapy. Angewandte Chemie (International Ed. in English). e202201103. PMID 35165986 DOI: 10.1002/anie.202201103 |
0.431 |
|
2020 |
Long Y, Cao B, Xiong X, Chan ASC, Sun RW, Zou T. Bioorthogonal Activation of Dual Catalytic and Anti-Cancer Activities of Organogold(I) Complexes in Living Systems. Angewandte Chemie (International Ed. in English). PMID 33151608 DOI: 10.1002/anie.202013366 |
0.321 |
|
2020 |
Teng T, Li K, Cheng G, Wang Y, Wang J, Li J, Zhou C, Liu H, Zou T, Xiong J, Wu C, Zhang HX, Che CM, Yang C. Lighting Silver(I) Complexes for Solution-Processed Organic Light-Emitting Diodes and Biological Applications via Thermally Activated Delayed Fluorescence. Inorganic Chemistry. PMID 32845614 DOI: 10.1021/Acs.Inorgchem.0C01054 |
0.525 |
|
2020 |
Luo H, Cao B, Chan ASC, Sun RW, Zou T. Cyclometalated Gold(III)-Hydride Complexes Exhibit Visible Light-Induced Thiol Reactivity and Act as Potent Photo-Activated Anti-Cancer Agents. Angewandte Chemie (International Ed. in English). PMID 32207866 DOI: 10.1002/Anie.202000528 |
0.494 |
|
2020 |
Luo H, Cao B, Chan ASC, Sun RW, Zou T. Inside Back Cover: Cyclometalated Gold(III)‐Hydride Complexes Exhibit Visible Light‐Induced Thiol Reactivity and Act as Potent Photo‐Activated Anti‐Cancer Agents (Angew. Chem. Int. Ed. 27/2020) Angewandte Chemie. 59: 11158-11158. DOI: 10.1002/Anie.202006642 |
0.465 |
|
2020 |
Luo H, Cao B, Chan ASC, Sun RW, Zou T. Innenrücktitelbild: Cyclometalated Gold(III)‐Hydride Complexes Exhibit Visible Light‐Induced Thiol Reactivity and Act as Potent Photo‐Activated Anti‐Cancer Agents (Angew. Chem. 27/2020) Angewandte Chemie. 132: 11252-11252. DOI: 10.1002/Ange.202006642 |
0.477 |
|
2019 |
Huang KB, Wang FY, Feng HW, Luo H, Long Y, Zou T, Chan ASC, Liu R, Zou H, Chen ZF, Liu YC, Liu YN, Liang H. An aminophosphonate ester ligand-containing platinum(ii) complex induces potent immunogenic cell death in vitro and elicits effective anti-tumour immune responses in vivo. Chemical Communications (Cambridge, England). PMID 31570904 DOI: 10.1039/C9Cc06563F |
0.439 |
|
2017 |
Zou T, Lok CN, Wan PK, Zhang ZF, Fung SK, Che CM. Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium. Current Opinion in Chemical Biology. 43: 30-36. PMID 29136524 DOI: 10.1016/J.Cbpa.2017.10.014 |
0.572 |
|
2017 |
Fung SK, Zou T, Cao B, Lee PY, Fung YM, Hu D, Lok CN, Che CM. Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets. Angewandte Chemie (International Ed. in English). PMID 28247451 DOI: 10.1002/Anie.201612583 |
0.587 |
|
2016 |
Yang C, Mehmood F, Lam TL, Chan SL, Wu Y, Yeung CS, Guan X, Li K, Chung CY, Zhou CY, Zou T, Che CM. Stable luminescent iridium(iii) complexes with bis(N-heterocyclic carbene) ligands: photo-stability, excited state properties, visible-light-driven radical cyclization and CO reduction, and cellular imaging. Chemical Science. 7: 3123-3136. PMID 29997803 DOI: 10.1039/C5Sc04458H |
0.557 |
|
2016 |
Fung SK, Zou T, Cao B, Chen T, To WP, Yang C, Lok CN, Che CM. Luminescent platinum(II) complexes with functionalized N-heterocyclic carbene or diphosphine selectively probe mismatched and abasic DNA. Nature Communications. 7: 10655. PMID 26883164 DOI: 10.1038/Ncomms10655 |
0.517 |
|
2016 |
Yang C, Mehmood F, Lam TL, Chan SLF, Wu Y, Yeung CS, Guan X, Li K, Chung CYS, Zhou CY, Zou T, Che CM. Stable luminescent iridium(III) complexes with bis(N-heterocyclic carbene) ligands: Photo-stability, excited state properties, visible-light-driven radical cyclization and CO2 reduction, and cellular imaging Chemical Science. 7: 3123-3136. DOI: 10.1039/c5sc04458h |
0.385 |
|
2016 |
Zou T, Zhang J, Cao B, Tong K, Lok C, Che C. Deubiquitinases as Anticancer Targets of Gold Complexes Israel Journal of Chemistry. 56: 825-833. DOI: 10.1002/Ijch.201600044 |
0.573 |
|
2016 |
Zou T, Zhang J, Cao B, Tong K, Lok C, Che C. ChemInform Abstract: Deubiquitinases as Anticancer Targets of Gold Complexes Cheminform. 47. DOI: 10.1002/chin.201648271 |
0.307 |
|
2015 |
Tsai JL, Zou T, Liu J, Chen T, Chan AO, Yang C, Lok CN, Che CM. Luminescent platinum(ii) complexes with self-assembly and anti-cancer properties: hydrogel, pH dependent emission color and sustained-release properties under physiological conditions. Chemical Science. 6: 3823-3830. PMID 29218152 DOI: 10.1039/C4Sc03635B |
0.559 |
|
2015 |
Andermark V, Göke K, Kokoschka M, Abu El Maaty MA, Lum CT, Zou T, Sun RW, Aguiló E, Oehninger L, Rodríguez L, Bunjes H, Wölfl S, Che CM, Ott I. Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex. Journal of Inorganic Biochemistry. PMID 26850306 DOI: 10.1016/J.Jinorgbio.2015.12.020 |
0.525 |
|
2015 |
Zou T, Sadler PJ. Speciation of precious metal anti-cancer complexes by NMR spectroscopy. Drug Discovery Today. Technologies. 16: 7-15. PMID 26547416 DOI: 10.1016/J.Ddtec.2015.08.002 |
0.515 |
|
2015 |
Zou T, Lum CT, Lok CN, Zhang JJ, Che CM. Chemical biology of anticancer gold(iii) and gold(i) complexes. Chemical Society Reviews. PMID 25868756 DOI: 10.1039/C5Cs00132C |
0.573 |
|
2015 |
Li K, Zou T, Chen Y, Guan X, Che CM. Pincer-Type Platinum(II) Complexes Containing N-Heterocyclic Carbene (NHC) Ligand: Structures, Photophysical and Anion-Binding Properties, and Anticancer Activities. Chemistry (Weinheim An Der Bergstrasse, Germany). 21: 7441-53. PMID 25828963 DOI: 10.1002/Chem.201406453 |
0.56 |
|
2015 |
Tsai JLL, Zou T, Liu J, Chen T, Chan AOY, Yang C, Lok CN, Che CM. Luminescent platinum(ii) complexes with self-assembly and anti-cancer properties: hydrogel, pH dependent emission color and sustained-release properties under physiological conditions Chemical Science. 6: 3823-3830. DOI: 10.1039/c4sc03635b |
0.416 |
|
2015 |
Zou T, Hung FF, Yang C, Che CM. Strongly Phosphorescent Transition-Metal Complexes with N-Heterocyclic Carbene Ligands as Cellular Probes Structure and Bonding. 165: 181-204. DOI: 10.1007/430-2015-173 |
0.466 |
|
2014 |
He L, Chen T, You Y, Hu H, Zheng W, Kwong WL, Zou T, Che CM. A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex. Angewandte Chemie (International Ed. in English). 53: 12532-6. PMID 25220408 DOI: 10.1002/Anie.201407143 |
0.536 |
|
2014 |
Zou T, Liu J, Lum CT, Ma C, Chan RC, Lok CN, Kwok WM, Che CM. Luminescent cyclometalated platinum(II) complex forms emissive intercalating adducts with double-stranded DNA and RNA: differential emissions and anticancer activities. Angewandte Chemie (International Ed. in English). 53: 10119-23. PMID 25044924 DOI: 10.1002/Anie.201405384 |
0.513 |
|
2014 |
Zou T, Lum CT, Lok CN, To WP, Low KH, Che CM. A binuclear gold(I) complex with mixed bridging diphosphine and bis(N-heterocyclic carbene) ligands shows favorable thiol reactivity and inhibits tumor growth and angiogenesis in vivo. Angewandte Chemie (International Ed. in English). 53: 5810-4. PMID 24729298 DOI: 10.1002/Anie.201400142 |
0.546 |
|
2014 |
Lok CN, Zou T, Zhang JJ, Lin IW, Che CM. Controlled-release systems for metal-based nanomedicine: encapsulated/self-assembled nanoparticles of anticancer gold(III)/platinum(II) complexes and antimicrobial silver nanoparticles. Advanced Materials (Deerfield Beach, Fla.). 26: 5550-7. PMID 24664412 DOI: 10.1002/Adma.201305617 |
0.51 |
|
2014 |
Shiu HY, Chong HC, Leung YC, Zou T, Che CM. Phosphorescent proteins for bio-imaging and site selective bio-conjugation of peptides and proteins with luminescent cyclometalated iridium(III) complexes. Chemical Communications (Cambridge, England). 50: 4375-8. PMID 24643302 DOI: 10.1039/C3Cc48376B |
0.444 |
|
2014 |
Lum CT, Wai-Yin Sun R, Zou T, Che CM. Gold(iii) complexes inhibit growth of cisplatin-resistant ovarian cancer in association with upregulation of proapoptotic PMS2 gene Chemical Science. 5: 1579-1584. DOI: 10.1039/C3Sc53203H |
0.513 |
|
2014 |
Lok CN, Zou T, Zhang JJ, Lin IWS, Che CM. Controlled-release systems for metal-based nanomedicine: Encapsulated/self-assembled nanoparticles of anticancer gold(III)/platinum(II) complexes and antimicrobial silver nanoparticles Advanced Materials. 26: 5550-5557. DOI: 10.1002/adma.201305617 |
0.42 |
|
2013 |
To WP, Zou T, Sun RW, Che CM. Light-induced catalytic and cytotoxic properties of phosphorescent transition metal compounds with a d8 electronic configuration. Philosophical Transactions. Series a, Mathematical, Physical, and Engineering Sciences. 371: 20120126. PMID 23776290 DOI: 10.1098/Rsta.2012.0126 |
0.437 |
|
2013 |
Zou T, Lok CN, Fung YM, Che CM. Luminescent organoplatinum(II) complexes containing bis(N-heterocyclic carbene) ligands selectively target the endoplasmic reticulum and induce potent photo-toxicity. Chemical Communications (Cambridge, England). 49: 5423-5. PMID 23515304 DOI: 10.1039/C3Cc40953H |
0.557 |
|
2013 |
Zou T, Lum CT, Chui SS, Che CM. Gold(III) complexes containing N-heterocyclic carbene ligands: thiol "switch-on" fluorescent probes and anti-cancer agents. Angewandte Chemie (International Ed. in English). 52: 2930-3. PMID 23371740 DOI: 10.1002/Anie.201209787 |
0.547 |
|
2013 |
Sun RWY, Lok CN, Fong TTH, Li CKL, Yang ZF, Zou T, Siu AFM, Che CM. A dinuclear cyclometalated gold(iii)-phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo Chemical Science. 4: 1979-1988. DOI: 10.1039/C3Sc21972K |
0.55 |
|
Show low-probability matches. |